Skip to main content
. 2023 Feb 3;12(3):1237. doi: 10.3390/jcm12031237

Figure 2.

Figure 2

Induction chemotherapy (ICT)-based larynx preservation (LP) program for a 62-year-old female patient with a T3N0 hypopharyngeal carcinoma: (a) initial CT scan of the tumor; (b) initial nasofibroscopy showing a T3 tumor invading the left pyriform sinus, and the aryepiglottic fold; (c) post-ICT CT scan showing a near-complete response to ICT (2 cycles of TPF: docetaxel, cisplatin and 5-fluorouracil); (d) post-ICT nasofibroscopy showing a near-complete response to ICT with larynx mobility recovery.